Graf Akcie GENE (Genetic Technologies Ltd.). Diskuze k akciím GENE. Aktuální informace GENE.

Základní informace o společnosti Genetic Technologies Ltd. (Akcie GENE)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 51.91M
Hodnota podniku (EV) N/A
Tržby AUD120.554k
EBITDA N/A
Zisk -AUD7.08
Růst v tržbách Q/Q 1,022.20 %
Růst v tržbách Y/Y 1,122.16 %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 268.07
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 588.33
P/FCF N/A
Price/Book 3.29
Účetní hodnota na akcii 0.92
Hotovost na akcii 0.89
FCF vůči ceně -10.07 %
Počet zaměstnanců 2,021
Tržba na zaměstnance AUD59.65
Profit margin -5,870.91 %
Operating margin -7,143.43 %
Gross margin -199.47 %
EBIT margin -7,143.43 %
EBITDA margin -48,586.78 %
EPS - Zisk na akcii -0.98
EPS - Kvartální růst N/A %
EPS - Očekávaný růst příští rok N/A %
Return on assets -33.85 %
Return on equity -36.28 %
ROIC -44.62 %
ROCE -39.93 %
Dluhy/Equity 0.07
Čistý dluh/EBITDA N/A
Current ratio 15.82
Quick Ratio 15.77
Volatilita 4.15
Beta 0.00
RSI 39.89
Cílová cena analytiků 5
Známka akcie (dle analytiků) N/A
Insider ownership 1.17 %
Institutional ownership 2.37 %
Počet akcií 15.377M
Procento shortovaných akcií 0.00 %
Short ratio 3.85 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2003
Země Australia

Finanční výsledky akcie GENE

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$0.007$0.018$0.147$0.65$0.82$2.542
Cost Of Goods Sold$0.169$0.198$0.233$0.371$0.541$0.746
Gross Profit$-0.162$-0.179$-0.086$0.279$0.278$1.797
Research And Development Expenses$1.664$1.688$1.714$1.784$1.883$2.385
SG&A Expenses$3.153$3.151$3.165$4.263$4.82$7.3
Other Operating Income Or Expenses$-0.014$-0.306$-0.022$-0.435$-0.097$-0.586
Operating Expenses$5$5.343$5.134$6.853$7.342$11.017
Operating Income$-4.993$-5.325$-4.987$-6.203$-6.522$-8.475
Total Non-Operating Income/Expense$0.898$0.729$0.751$-0.133$0.359$1.105
Pre-Tax Income$-4.095$-4.596$-4.236$-6.336$-6.163$-7.37
Income Taxes------
Income After Taxes$-4.095$-4.596$-4.236$-6.336$-6.163$-7.37
Other Income------
Income From Continuous Operations$-4.095$-4.596$-4.236$-6.336$-6.163$-7.37
Income From Discontinued Operations------
Net Income$-4.095$-4.596$-4.236$-6.336$-6.163$-7.37
EBITDA$-4.993$-5.325$-4.987$-6.203$-6.522$-8.475
EBIT$-4.993$-5.325$-4.987$-6.203$-6.522$-8.475
Basic Shares Outstanding744432
Shares Outstanding744432
Basic EPS$-0.60$-1.05$-1.02$-1.79$-2.16$-4.12
EPS - Earnings Per Share$-0.60$-1.05$-1.02$-1.79$-2.16$-4.12
# 2020 2019 2018 2017 2016 2015
Current Ratio10.87082.14054.12957.93819.106111.2762
Long-term Debt / Capital0.0182-----
Debt/Equity Ratio0.037-----
Gross Margin-2449.787-985.7872-58.563642.91633.958170.6738
Operating Margin-75379.38-29261.88-3398.817-953.8354-795.5477-333.3665
EBIT Margin-75379.38-29261.88-3398.817-953.8354-795.5477-333.3665
EBITDA Margin-75379.38-29261.88-3398.817-953.8354-795.5477-333.3665
Pre-Tax Profit Margin-61830.19-25253.97-2887.058-974.2233-751.8184-289.897
Net Profit Margin-61830.19-25253.97-2887.058-974.2233-751.8184-289.897
Asset Turnover0.00060.00780.03070.07120.08470.1467
Inventory Turnover Ratio2.7521-----
Receiveable Turnover0.01250.03110.6282.02361.78374.2507
Days Sales In Receivables29208.6611745.42581.2548180.3687204.626485.8675
ROE - Return On Equity-46.8594-362.7827-115.9594-79.4384-71.1843-46.469
Return On Tangible Equity-46.8594-362.7813-115.9595-79.4384-75.026-48.3459
ROA - Return On Assets-39.0132-196.8023-88.6132-69.4055-63.6506-42.5207
ROI - Return On Investment-46.008-362.7813-115.9595-79.4384-71.1843-46.469
Book Value Per Share0.69790.25870.89981.96443.02865.5452
Operating Cash Flow Per Share0.4350.08460.37960.51632.5665.9766
Free Cash Flow Per Share0.44310.07680.41810.55292.55395.955